Benzodiazepines (Psy and mixed indications) updated on 02-10-2025

Gestational diabetes

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17712
R74713		 Hironaka - BZDs (Control exposed to Atypical antipsy), 2011 Gestational diabetes mellitus during pregnancy (anytime or not specified) retrospective cohort exposed to other treatment, sick excluded Adjustment: No BZD Coexposure: Not specified Indication BZD: Psychiatric diseases (depression, anxiety, ...) 1.89 [0.03;112.07] C
excluded (control group) 		0/5   0/9 0 5
ref
S17710
R74701		 Hironaka - BZDs (Control unexposed, disease free), 2011 Gestational diabetes mellitus during pregnancy (anytime or not specified) retrospective cohort unexposed, disease free excluded Adjustment: No BZD Coexposure: Not specified Indication BZD: Psychiatric diseases (depression, anxiety, ...) 20.48 [0.73;574.19] C
excluded (control group) 		0/5   1/278 1 5
ref
S17711
R74707		 Hironaka - BZDs (Control unexposed, sick), 2011 Gestational diabetes mellitus during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No BZD Coexposure: Not specified Indication BZD: Psychiatric diseases (depression, anxiety, ...) 0.56 [0.01;37.57] C 0/5   0/3 0 5
ref
Total 1 studies 0.56 [0.01;37.57] 0 5
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Hironaka - BZDs (Control unexposed, sick), 2011Hironaka - BZDs, 2011 1 0.56[0.01; 37.57]050%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Control unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 Tags Adjustment   - No  - No 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 BZD Coexposure   - Not specified  - Not specified 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 Indication BZD   - Psychiatric diseases (depression, a ...  - Psychiatric diseases (depression, anxiety, ...) 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 All studiesAll studies 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 10.210.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 17712, 17710

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) Out of scale20.48[0.73; 574.19]15 -NAHironaka - BZDs (Control unexposed, disease free), 2011 1 unexposed, sick controlsunexposed, sick controls 0.56[0.01; 37.57]-5 -NAHironaka - BZDs (Control unexposed, sick), 2011 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.89[0.03; 112.07]-5 -NAHironaka - BZDs (Control exposed to Atypical antipsy), 2011 10.510.01.0